Clinical Trial Update: A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer

View source ↗

Summary

The study evaluates photon- and proton-based chemoradiotherapy as definitive or neoadjuvant therapy for non-metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Pancreatic Cancer | Status: ACTIVE_NOT_RECRUITING